LPCN 2202

N/A

Report date: 2025/12/17 13:17:34
NME

Base Information

Drug NameLPCN 2202
Drug Alias NameLPCN 2202LPCN-2202
ClassificationSmall molecules > Steroids
Mechanisms of ActionGamma-aminobutyric acid A receptor positive allosteric modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLipocine Inc
China Registration ClassN/A

Develop Information

Active CompaniesLipocine Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A